Optimizing Comprehensive Care and Referral Strategies for the Optometrist WebCAST
Webcast CME Disclosure
Please read this notice and click the acknowledgement
at the bottom of the page to continue.
Program Medium
Internet-based program
Estimated Time to Complete Educational Activity
2.5 hours
Course Overview
In this web-based program, physicians and optometrists will learn how recent developments in retinal screening have helped to advance the management of diabetic macular edema and age related macular degeneration.
Release Date
March 16, 2017
Expiration Date
March 16, 2019
Method of Physician Participation Utilized in Learning Process
There are no fees for participating and receiving CME credit for this activity. During the period March 17,2017 through March 17, 2019 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all 6 segments totaling 2.5 hours to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out your CME certificate.
Registration
Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Grantor Support
Supported by an educational grant from Regeneron Pharmaceuticals
Accreditation Statement
This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Medical School and CMEducation Resources, LLC. University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Massachusetts Medical School designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Faculty & Provider Disclosure
It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Other Credits
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™from organizations accredited by the ACCME.
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Program Faculty and Disclosure
PAUL M. KARPECKI, OD, FAAO
Clinical Director
Kentucky Eye Institute
Retina Associates of Kentucky
Lexington KY
Consultant: Aerie Pharmaceuticals, Akorn, Alcon, Allergan, AMO, Anthem, Avellino Labs, Bausch + Lomb, Beaver Visitech, BioTissue, Cambium Pharmaceuticals, Calhoun Vision, Candor Pharmaceuticals, Essilor, eyeBrain, Eyemaginations/Rendia, Eyes4Lives, Focus Labs, iCare USA, Imprimis, Katena, Konan Medical, Lubris Inc, Maculogix, Ocular Therapeutix, Oculus, OcuSoft, Paragon Biotek, PECAA, Perrigo, Quark Pharmaceuticals, Regeneron, Reichert/Ametek, Retina Sciences, RySurg, Science Based Health, Shire Pharmaceuticals, Sun Pharmaceuticals, TearFilm Innovation, TearScience, TelScreen, Topcon, Visiometrics, Vision Care Inc, Vmax
Research Grant: Shire Pharmaceuticals
Speaker’s Bureau: Shire Pharmaceuticals
Ownership Interest: Bruder Healthcare, Eye Therapies, Optometric Medical Solutions, TearLab
RISHI P. SINGH, MD
Staff Physician
Cleveland Clinic Cole Eye Institute
Assistant Professor of Ophthalmology
Case Western Reserve University
Cleveland, OH
Consultant: Genentech, Regeneron, Shire, Zeiss, Optos
Grant/Research Support: Regeneron, Alcon, Genentech, Apellis
MARK T. DUNBAR, OD, FAAO
Director of Optometry
University of Miami, Bascom Palmer Eye Institute
Miami, FL
Speaker’s Bureau: Regeneron, Genentech
VIVIAN A. FONSECA, MD, FRCP
Professor of Medicine and Pharmacology
Tulis-Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
President, Science and Medicine (2012)
American Diabetes Association (ADA)
Consulting and Lectures: Takeda, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Pamlabs, Astra Zeneca, Abbott, Amgen, Boehringer Ingelheim, Janssen
Research Support (to Tulane): Grants from Novo-Nordisk, Asahi, Eli Lilly, Abbott, Endo Barrier, Gilead Sciences
Program Managers and Web Editor Disclosure
Program Manager Gideon Bosker, MD has nothing to disclose. Program reviewer Denise Leary has nothing to disclose.
Educational Objectives
Upon completion of this activity, participants will be able to:
- Detail the practical, case-based and guideline-consistent approaches for the optometry specialist when screening a broad range of patients at risk for age-related macular degeneration (AMD) and diabetic macular edema (DME);
- Apply optometry-focused screening methodologies—among them, in-office/in-clinic screening devices, evolving technologies for evaluation of retinal disease, dilated eye exams, telemedicine technology, optometrist-based screening and referral etc.—to optimize detection and referral to retina specialists for definitive treatment and prevention of progressive eye pathology and blindness in the setting of optometry and diabetes practice;
- Understand the disease burden, epidemiology, consequences, identification, disease state classification, and multiple clinical manifestations and symptoms of DME, AMD, and related conditions as they present to the front lines of optometry practice;
- Apply at the front lines of optometry practice national association guidelines for systematic screening and eye findings-directed referral to retina specialists;
- Recognize which patient populations should be screened in the optometry and diabetes specialist setting and how often, and what specific technologies should be used to optimize detection of DME and AMD.
Hardware and Software Requirements:
To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.
Privacy Policy
When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:
- We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
- For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
- We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
- If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
- You should check this privacy policy periodically to see whether we have made any changes.